This trial is active, not recruiting.

Condition abnormalities, cardiovascular
Sponsor Michael Buonocore, MD, PhD
Start date May 1999
End date January 2015
Trial size 120 participants
Trial identifier NCT00593541, 200210689


This Protocol is intended to facilitate development and testing of new cardiovascular MRI software capabilities by UC Davis Research Faculty, as well as to facilitate the evaluation of new software capabilities provided by GE and Siemens.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective

Primary Outcomes

Extend or generalize certain capabilities, such as new data acquisition pulse sequences, new image processing and analysis software for structural and functional analysis of the MR images
time frame: Post-scanning

Secondary Outcomes

Improve image quality by various techniques (e.g. reducing the effects of motion)
time frame: Post-scanning

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - 18 years of age or older - Ability to give informed, written consent - Not Pregnant or breastfeeding Exclusion Criteria: - Electrically, magnetically, or mechanically activated implants (for example, cardiac-pacemakers) - Ferromagnetic implant, such as an aneurysm clip, surgical clip, or prosthesis - History of uncontrolled claustrophobia

Additional Information

Official title Development of New Software Capabilities for Use With Cardiovascular Magnetic Resonance Imaging
Principal investigator Michael H Buonocore, MD, PhD
Description This protocol will permit normal subjects, as well as patients with suspected or proven medical conditions, to undergo MRI studies using the new software capabilities. This Protocol is not restricted to imaging of a particular organ system or disease. The Protocol does not involve injection of any contrast agent, or other minimally-invasive or invasive procedure. It is intended only for those cases for which the only requirement of the subject is to relax and lie still while imaging is being performed.
Trial information was received from ClinicalTrials.gov and was last updated in October 2012.
Information provided to ClinicalTrials.gov by University of California, Davis.